𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BAY 63–2521, an oral soluble guanylate cyclase stimulator, has a favourable safety profile and decreases peripheral vascular resistance in healthy male volunteers

✍ Scribed by Reiner Frey; Wolfgang Mück; Sigrun Unger; Ulrike Artmeier-Brandt; Gerrit Weimann; Georg Wensing

Publisher
BioMed Central
Year
2007
Tongue
English
Weight
411 KB
Volume
7
Category
Article
ISSN
1471-2210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BAY 58–2667, a soluble guanylate cyclase
BAY 58–2667, a soluble guanylate cyclase activator, has a favourable safety profile and reduces peripheral vascular resistance in healthy male volunteers
✍ Reiner Frey; Wolfgang Mück; Sigrun Unger; Ulrike Artmeier-Brandt; Gerrit Weimann 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 416 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.

BAY 63–2521, an oral soluble guanylate c
BAY 63–2521, an oral soluble guanylate cyclase stimulator, has a favourable safety profile, improves cardiopulmonary haemodynamics and has therapeutic potential in pulmonary hypertension
✍ Ardeschir Hossein Ghofrani; Gerrit Weimann; Reiner Frey; Robert Voswinckel; Mela 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 410 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.